Effects of Ganoderma Lucidum (Higher Basidiomycetes) Extracts on the MiRNA Profile and Telomerase Activity of the MCF-7 Breast Cancer Cell Line
Overview
Rehabilitation Medicine
Authors
Affiliations
Ganoderma lucidum is a medicinal higher Basidiomycetes mushroom that exerts anticancer effects through several different mechanisms. This study investigated the effects of G. lucidum on the telomerase activity and microRNA (miRNA) profiles of MCF-7 cells. According to the cytotoxicity results, the G. lucidum ether extract exhibits the highest cytotoxic potency; therefore it was chosen for the subsequent telomerase activity assay and miRNA profiling. The telomerase activity observed in the cells treated with a half-maximal inhibitory concentration of G. lucidum ether extract (100 µg/mL in dimethyl sulfoxide) was 32.2% lower than that of the control cells treated with 1% dimethyl sulfoxide. Among 1066 miRNAs, the most downregulated miRNA was hsa-miR-27a* (4.469-fold), and the most upregulated miRNA was hsa-miR-1285 (10.462-fold). A database search revealed the predicted miRNAs that target the catalytic subunit of the telomerase enzyme telomerase reverse transcriptase, and only miR-3687 (upregulated 2.153-fold) and miR-1207-5p (upregulated 2.895-fold) were changed by at least 2-fold. The miRNA profile changes demonstrated in this study provide a data set regarding their effects on the pathways that regulate telomerase activity in MCF-7 breast cancer cells treated with G. lucidum. These data should aid the development of novel cancer treatment strategies.
Hu Y, Dingerdissen H, Gupta S, Kahsay R, Shanker V, Wan Q Comput Biol Med. 2018; 103:183-197.
PMID: 30384176 PMC: 6279243. DOI: 10.1016/j.compbiomed.2018.10.021.
Graham E, Mallet J, Jambi M, Nishioka H, Homma K, Matar C Cancer Biol Ther. 2017; 18(10):765-774.
PMID: 28886271 PMC: 5678688. DOI: 10.1080/15384047.2017.1373211.
spp.: A Promising Adjuvant Treatment for Breast Cancer.
Suarez-Arroyo I, Loperena-Alvarez Y, Rosario-Acevedo R, Martinez-Montemayor M Medicines (Basel). 2017; 4(1).
PMID: 28758107 PMC: 5533290. DOI: 10.3390/medicines4010015.
Metabolism-related microRNAs in maternal breast milk are influenced by premature delivery.
Carney M, Tarasiuk A, DiAngelo S, Silveyra P, Podany A, Birch L Pediatr Res. 2017; 82(2):226-236.
PMID: 28422941 PMC: 5552431. DOI: 10.1038/pr.2017.54.
Starska K, Forma E, Nowacka-Zawisza M, Lewy-Trenda I, Ciesielski P, Pietruszewska W Tumour Biol. 2015; 37(4):4541-57.
PMID: 26503213 DOI: 10.1007/s13277-015-4276-3.